Skip NavigationSkip to Content
Return Return to Search Results

The proteasome inhibitor, bortezomib (Formerly PS-341), sensitizes tumor cells to adherent lymphokine activated killer (ALAK) cell-mediated killing

  1. Author:
    Hallett, W.
    Barao, I.
    Sayers, T.
    Murphy, W.

  2. Author Address

    Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA. SAIC Frederick, Expt Immunol Lab, Frederick, MD USA. Nevada Canc Inst, Div Basic Res, Las Vegas, NV USA
    1. Year: 2004
    2. Date: NOV-DEC
  2. Journal: Journal of Immunotherapy
    1. 27
    2. 6
    3. Pages: S50-S50
  4. Type of Article: Meeting Abstract
  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000224902800182

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel